Results 241 to 250 of about 108,435 (311)

Gastrointestinal strictures in a pediatric patient with Satoyoshi syndrome

JPGN Reports, EarlyView.
Abstract We present a novel case of gastrointestinal strictures in a young girl with Satoyoshi syndrome (SS), highlighting multi‐system features of alopecia universalis, painful muscle cramps with dystonia, aberrant growth velocity, and skeletal abnormalities.
Katherine (Tusia) Pohoreski, Gary Galante, Kiera Pajunen, Marie‐Anne Brundler, Samarjeet Bhandal, Iwona Wrobel   +5 more
wiley   +1 more source

A Novel Scoring System for the Administration of an IgM- and IgA-Enriched Intravenous Immunoglobulin Preparation: The SORRISO Score. [PDF]

J Clin Med
Bixio M, Torelli L, Scamperle A, Quarantotto G, Zanchi S, Baronio S, Mirabella L, Conti A, Forfori F, Noto A, Bonato V, Cortegiani A, Botter E, Chillemi A, Longo I, Dattola R, Berlot G.   +16 more
europepmc   +1 more source

Dupilumab and Systemic Hematologic Malignancies: Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic inflammatory skin disease affecting 15%–20% of children and 3%–10% of adults. An increased risk of systemic lymphomas – but not leukemias – has been reported in patients with AD. Dupilumab, a monoclonal IgG4 antibody targeting IL‐4 and IL‐13 signaling, is approved for moderate‐to‐severe AD and is ...
Nello Tommasino, Cataldo Patruno, Francesca di Vico, Maddalena Napolitano   +3 more
wiley   +1 more source

Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study. [PDF]

Pediatr Rheumatol Online J
Hatano S, Nakao H, Masuda H, Ono H, Kubota M, Ishiguro A.   +5 more
europepmc   +1 more source

Dermatomyositis Like Presentation of Anti‐HMGCR Immune Mediated Necrotising Myopathy

JEADV Clinical Practice, EarlyView.
ABSTRACT Extramuscular manifestations of anti‐3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMGCR) immune‐mediated necrotising myopathy (IMNM) are rare and often overlooked because they are overshadowed by predominant muscular symptoms. The types of cutaneous manifestations can be numerous.
Lionel Leblanc, Lyna Mtimet, Louis Wolff, Evelyne Berlingin, Bruno Couturier   +4 more
wiley   +1 more source

Five-Year Experience of Etanercept as Adjunct to Intravenous Immunoglobulin for Kawasaki Disease with Coronary Artery Involvement. [PDF]

J Pediatr Clin Pract
Rogers R, Sagiv E, Olson AK, Portman MA.
europepmc   +1 more source

Exposure to intravenous immunoglobulin is associated with increased mortality in patients on immune checkpoint inhibitors: A population-based cohort study. [PDF]

JAAD Int
Cheng D, Nguyen NTT, Thang CJ, Burke OM, LeBoeuf NR, Theodosakis N, Semenov YR.   +6 more
europepmc   +1 more source

Association between C-reactive protein-albumin-lymphocyte (CALLY) index with intravenous immunoglobulin non-response in Kawasaki disease. [PDF]

Ann Med
Duan Y, Wang T, Jia P, Deng L, Song Z, Liu B, Jiang J, Liu D, Li G.   +8 more
europepmc   +1 more source

Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin. [PDF]

JAAD Case Rep
McNamara ME, Tjahjono L.
europepmc   +1 more source

Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a randomised, double-blind, placebo-controlled trial. [PDF]

BMJ Open
Nørgaard-Pedersen C, Kesmodel US, Jørgensen MM, Christiansen O.   +3 more
europepmc   +1 more source